1. Home
  2. PRAX vs BPOP Comparison

PRAX vs BPOP Comparison

Compare PRAX & BPOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$331.79

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Popular Inc.

BPOP

Popular Inc.

HOLD

Current Price

$143.82

Market Cap

8.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
BPOP
Founded
2015
1893
Country
United States
United States
Employees
N/A
9427
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRAX
BPOP
Price
$331.79
$143.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
11
Target Price
$572.13
$152.64
AVG Volume (30 Days)
345.8K
437.8K
Earning Date
05-01-2026
04-23-2026
Dividend Yield
N/A
2.07%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.33
Revenue Next Year
$6,395.88
$6.02
P/E Ratio
N/A
$11.87
Revenue Growth
N/A
N/A
52 Week Low
$28.79
$82.88
52 Week High
$354.87
$149.31

Technical Indicators

Market Signals
Indicator
PRAX
BPOP
Relative Strength Index (RSI) 57.17 64.16
Support Level $282.49 $123.14
Resistance Level $327.65 $149.23
Average True Range (ATR) 17.60 3.07
MACD 2.86 1.50
Stochastic Oscillator 81.68 78.83

Price Performance

Historical Comparison
PRAX
BPOP

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About BPOP Popular Inc.

Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.

Share on Social Networks: